stockrowOrganogenesis (ORGO) vs Talphera, Inc. (TLPH)
- Organogenesis ORGO 0.86 +2.38%
- Talphera, Inc. TLPH 1.06 +4.95%
Organogenesis and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. Organogenesis is the larger, with a market value of $108.1M against $52.4M — 2.1× the size. Organogenesis grew revenue faster over the last twelve months: −24.3% against −73.1%. Talphera, Inc. has the higher net margin (0.00% vs −43.5%) and the higher return on invested capital (0.00% vs −52.2%). Across the 19 metrics below, Organogenesis leads on 12 and Talphera, Inc. on 7.
Valuation
Profitability
| Metric | ORGO | TLPH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.56% | 100.00% | 53.51% |
| Operating margin | (24.45%) | 0.00% | 0.00% |
| Net margin | (43.50%) | 0.00% | (2.45%) |
| Free cash flow margin | 1.01% | 0.00% | 0.00% |
| Return on equity | (81.71%) | (143.36%) | (0.80%) |
| Return on assets | (34.86%) | (69.60%) | (1.67%) |
| Return on invested capital | (52.15%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack